TP53 rs1042821: Understanding the Arg72Pro Variant
The rs1042821 variant, commonly known as the Arg72Pro polymorphism, is a well-studied genetic change in the TP53 gene. It is frequently investigated by researchers for its potential role in influencing cancer susceptibility and how cells respond to stress.
What each genotype means
Arginine homozygous genotype
This genotype results in the presence of the arginine amino acid at codon 72 of the p53 protein. Research into this variant is extensive and often conflicting, with some studies suggesting it may influence cancer susceptibility or clinical outcomes in specific populations, while others find no significant association. It is important to remember that this is a common polymorphism and not a diagnostic indicator of disease.
This is a very common genotype found globally, though its frequency varies significantly across different ancestral populations.
Heterozygous genotype
This genotype means you carry one copy of the arginine-encoding allele and one copy of the proline-encoding allele at codon 72. Scientific literature has investigated whether this combination affects cellular stress responses or cancer risk, but results remain inconsistent across different studies and ethnic groups. This variation is considered a normal part of human genetic diversity.
This heterozygous state is frequently observed in most human populations worldwide.
Proline homozygous genotype
This genotype results in the presence of the proline amino acid at codon 72 of the p53 protein. Some research has explored potential links between this genotype and altered cancer risk or survival outcomes in specific clinical contexts, such as certain lung or colorectal cancers, but these findings are not universal and often vary by population. This genotype is a common variation and does not imply a medical condition.
This genotype is common, though it is generally less frequent than the arginine-homozygous state in many populations.
What is rs1042821?
The rs1042821 variant is a single nucleotide polymorphism (SNP) located within the TP53 gene. In genetic terms, this specific change involves a substitution of the nucleotide guanine (G) for cytosine (C) at a specific position in the gene's sequence. This change results in an amino acid substitution in the p53 protein, where the amino acid arginine is replaced by proline at codon 72. Because this variant is common in the general population, it is classified as a polymorphism rather than a rare mutation. Scientists study this site extensively because the p53 protein plays a critical role in maintaining genomic stability, and even minor structural variations can be the subject of intense investigation regarding their functional impact on cellular health.
The Role of the TP53 Gene
The TP53 gene provides instructions for making the p53 protein, which acts as a tumor suppressor. Often referred to as the 'guardian of the genome,' p53 is essential for preventing cells from growing and dividing too rapidly or in an uncontrolled way. When DNA damage occurs, the p53 protein helps determine whether the cell should pause its cycle to repair the damage or undergo programmed cell death, known as apoptosis. By regulating these processes, p53 helps prevent the development of tumors. Because of its central role in cell cycle control, variations in the TP53 gene are of significant interest to researchers studying how genetic differences might influence an individual's susceptibility to various types of cancer or their body's response to environmental stressors.
Research and Associations
Research into rs1042821 has produced a wide range of findings, often with mixed or ancestry-specific results. Numerous studies have investigated whether the Arg72Pro variant is associated with an increased risk for various cancers, including breast, lung, gastric, and thyroid cancers. For example, some meta-analyses have suggested that the Pro variant may contribute to cancer risk in specific populations, such as Asian or Moroccan cohorts. However, other studies have found no significant association between this polymorphism and certain types of leukemia or other malignancies. The evidence strength for these associations is generally considered moderate, as results often vary significantly based on the population studied, the type of cancer, and other environmental factors. It is important to note that these findings represent statistical associations in research groups and do not imply a direct cause-and-effect relationship for any individual.
Understanding Your Information
Genetic information regarding variants like rs1042821 is complex and should be interpreted with caution. While this SNP is a common topic in molecular epidemiology, it is not a diagnostic tool for cancer. Having a particular genotype does not mean an individual will develop a disease, nor does it guarantee protection against one. Cancer is a multifactorial condition influenced by a combination of genetics, lifestyle, and environmental exposures. If you have questions about your genetic profile or concerns about cancer risk, it is essential to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal and family medical history. Never use information about a single SNP to make medical decisions or change your health habits without professional guidance.
How common is this variant?
The rs1042821 variant is a common polymorphism found across global populations, with varying frequencies of the G and C alleles depending on ancestral background.
Frequently asked questions
Is rs1042821 a cancer-causing mutation?
No, rs1042821 is a common polymorphism, not a disease-causing mutation. While researchers study its potential influence on cancer susceptibility, it is not a direct cause of cancer.
Should I be worried if I have the CC genotype?
The CC genotype is a common genetic variation found in many healthy individuals. It is not a diagnostic marker, and you should not be worried based on this result alone.
Can I use this information to predict my cancer risk?
No, this variant cannot be used to predict individual cancer risk. Cancer is a complex disease influenced by many genetic and environmental factors that a single SNP cannot account for.
Where can I learn more about my specific genetic results?
If you have questions about your genetic data, you should speak with a genetic counselor or your primary healthcare provider. They can help you interpret your results in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042821?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
Pathogenic missense variant (p.Arg248Gln) associated with Li-Fraumeni syndrome.
Functional codon 72 polymorphism (Arg72Pro) affecting apoptotic capability and associated with differential susceptibility to multiple cancer types.
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.
Pathogenic hotspot variant (p.Arg273His) in TP53 predisposing carriers to early-onset sarcomas, breast cancers, and leukemias.
Li-Fraumeni syndrome missense variant (p.Arg248Trp) causing loss of tumor suppressor function and multi-cancer predisposition.
Synonymous and regulatory variant in linkage with TP53 codon 72 that modulates blastocyst implantation competence and the risk of recurrent implantation failure.